Trades of Eli Lilly shares were made on Trump’s behalf as drugmaker benefitted from his policies
- Posted on May 19, 2026
- By The Guardian
- 0 Views
- 1 min read
Trades of Eli Lilly shares were made on Trump’s behalf as drugmaker benefitted from his policies
Filings reveal $220m to $750m in trades on US president’s behalf in first quarter of 2026, including securities linked to largest US companies
